Rivaroxaban
Back to searchMolecule Structure
Scientific Name
Rivaroxaban
Description of the Drug
Rivaroxaban is a factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06228
http://www.drugbank.ca/drugs/DB06228
Brand Name(s)
Xarelto
Company Owner(s)
Janssen Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Coagulation factor X | SINGLE PROTEIN | INHIBITOR | CHEMBL244 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3914 | |
| DrugBank | DB06228 | |
| PubChem: Thomson Pharma | 14856850 | 15279667 |
| PubChem | 9875401 | |
| LINCS | LSM-5499 | |
| Nikkaji | J2.395.184C | |
| PDBe | RIV | |
| BindingDB | 7840 | |
| DrugCentral | 4182 | |
| Brenda | 85908 | 4737 |
| ChemicalBook | CB82511258 | CB91176772 |
| Guide to Pharmacology | 6388 | |
| rxnorm | XARELTO | RIVAROXABAN |
| PubChem: Drugs of the Future | 22395270 | |
| ChEBI | 68579 | |
| ZINC | ZINC000003964126 |
